Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Clinical trial NCT05376566 · COMPLETED

Trial details

NCT number: NCT05376566
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Central Line-associated Bloodstream Infection (CLABSI)

Start date: 2022-06-01
Primary completion: 2026-03-01
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.